Schedule 13G ownership disclosure

Ovid therapeutics, Inc.

Common Stock, par value $0.001 per share (the "Common Stock") · CUSIP: 690469101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Madison Avenue Partners, LP

    Shares: 2,852,352 · Class: 4%

  • Madison Avenue International LP

    Shares: 2,852,352 · Class: 4%

  • EMAI Management, LLC

    Shares: 2,852,352 · Class: 4%

  • Madison Avenue GP, LLC

    Shares: 2,852,352 · Class: 4%

  • Caraway Jackson Investments LLC

    Shares: 2,852,352 · Class: 4%

  • Eli Samaha

    Shares: 2,852,352 · Class: 4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-25-000311
Form type
SCHEDULE 13G/A
Filer
Madison Avenue Partners, LP
CIK
CIK 1801265
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub